相关实验视频

Updated: Aug 21, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

使用基于斑块抑制试验的方法对抗HSV-1的抗病毒化合物的查和验证

Yingxian Yin¹, Jiahui Li², Ling Su³

¹Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, China.

BMC infectious diseases

|December 20, 2023

概括

研究人员确定了五种具有强烈抗疹简单病毒1型 (HSV-1) 活性的化合物,包括克林纳素HCl. 这些新型抗病毒药物对治疗HSV-1感染有前途,解决目前治疗方法的局限性.

科学领域:

病毒学病毒学
药理学药理学是指药理学的学科.
药物发现药物发现药物发现

背景情况:

简单疹病毒1型 (HSV-1) 通常会导致口腔,有时是生殖器的病变.
由于新兴的药物耐药性,现有的治疗方法面临挑战.
对于新型抗HSV-1疗法有极大需求.

研究的目的:

为了选一种复合物库的新型抗HSV-1药物.
识别具有针对HSV-1的强有力的抗病毒活性的化合物.
评估已识别的化合物的治疗潜力.

主要方法:

使用斑块形成试验选了2080种化合物.
选择了11种潜在的HSV-1抑制剂进行进一步评估.
通过减少斑块的测定和qPCR评估了抗病毒作用.

主要成果:

五种化合物表现出强大的抗HSV-1活性,在10μM时抑制斑块形成.
鉴定了金色化物Rd,布拉西诺利德,罗萨穆林,3'-基氨酸和克利纳弗洛克萨HCl.
诺基诺隆的一种克利纳弗洛克萨HCl对HSV-1具有很高的选择性.

结论:

这五种已识别的化合物具有针对HSV-1的潜在抗病毒特性.
这些化合物可能通过不同的作用机制起作用.
需要进一步的研究来阐明机制和治疗潜力.

关键词:

抗病毒药物查对抗病毒药物查在HSV-1病毒中,形成斑块的形成.斑块抑制试验斑块抑制试验

更多相关视频

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Published on: September 20, 2021

Plaquing of Herpes Simplex Viruses

Plaquing of Herpes Simplex Viruses

Published on: November 5, 2021

相关概念视频

Herpes

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...